Cancer Trials Ireland becomes Nestlé Ireland staff charity

Eibhlín Mulroe, CEO, Cancer Trials Ireland and Kieran Conroy, country manager, Nestlé Ireland

Partnership to raise awareness and funds to benefit the work of Cancer Trials Ireland

Print

PrintPrint
Brand Central

7 June 2022

Share this post:
 

advertisement



 

Cancer Trials Ireland is the new Staff Charity of the Year for Nestlé Ireland which aims to raise over €100,000 to assist Cancer Trials Ireland in its work to provide every patient diagnosed with cancer access to high-quality and potentially life-altering cancer trials.

The announcement is part of Nestlé’s community partnership programme which involves Nestlé Ireland supporting worthy causes that make a real difference in communities nationwide. Staff at Nestlé Ireland’s Citywest HQ selected Cancer Trials Ireland following an internal vote with staff committing to a range of awareness and fundraising initiatives over the duration of the partnership. To date, almost 31,000 (30,770) people have taken part in nearly 800 (786) cancer clinical trials.

Cancer Trials Ireland is partly funded by the Health Research Board and the Irish Cancer Society. It also receives income from pharmaceutical companies and international research groups, as well through philanthropic giving and donations from members of the public.

Nestlé Ireland is committed to being a force for good and our staff charity programme is a demonstration of this commitment in action,” said Nestlé Ireland country manager, Kieran Conroy.

“Since we launched the Charity of the Year Programme a number of years ago, our staff have raised over €750,000 for a range of important causes which are making a valuable impact on the lives of people in communities across Ireland,” he added.

“We are particularly pleased to announce Cancer Trials Ireland as our charity partner for 2022-2024 and we are looking forward to supporting the important work of Cancer Trials Ireland in the coming years through a range of actions which will highlight the critical work that they do through providing access to life-altering trials and helping to make an enormous impact on the lives of people diagnosed with cancer.”

 

advertisement



 
Share this post:



Back to Top ↑

Shelflife Magazine